Gene Microarray Core Facility

核心B：该中心提案的总体目标是开发有效的诊断、预后和 针对NIAID A-C类病原体的治疗措施。特别是，我们希望建立 体外和体内暴露于A-C类病原体的人类细胞的生物特征。在这方面 该微阵列核心的主要目的是为中心的研究者提供微阵列方面的专业知识 人类细胞的基因表达分析。 我们的长期目标是建立血液白细胞的微阵列分析作为一种平台技术， 生物威胁暴露的诊断和关于治疗的决策，在更大的范围内， 公共卫生癌症中基因表达的微阵列分析已经投入临床实践， 乳腺癌患者的常规预后筛查。我们的初步结果表明， 微阵列血液分析在系统性红斑狼疮患者中的诊断和预后价值， 从而将该技术的应用扩展到癌症之外并扩展到免疫功能障碍。 我们的策略将基于对人类细胞对不同类型的免疫应答的全面分析。 体外和体内的病原微生物。这将允许鉴定共同的分子宿主 不同微生物感染引起的生物特征，及时诊断接触情况并确定 病原体的种类该核心的目标是提供基于Affyscore的基因表达模式分析 在体外和体内暴露于A-C类病原体的人类细胞。目标是： 1)在中心内建立和分发相关的标准操作规程（SOP）。 2)使用Affyphin技术和GeneSpring表达分析软件分析样品， 从中心的研究人员处获得。 3)通过实时荧光定量PCR验证候选基因的表达水平。 4)组织和维护LIMS和Microsoft Access数据库系统，其中包含500多个样品。 5)能够跟上行业的发展，尤其是技术和分析软件的发展. 核心将为几乎所有中心的研究者提供支持和专业知识。

Core B: The overall goal of this Center proposal is to develop effective diagnostic, prognostic and therapeutic measures against NIAID Category A-C pathogens. In particular, we wish to establish biosignatures of human cells exposed in vitro and in vivo to Category A-C pathogens. In this context, the main purpose of this Microarray Core will be to provide Center's Investigators with expertise in microarray gene expression analysis of human cells. Our long term goal is to establish microarray analysis of blood leukocytes as a platform technology for the diagnosis of biothreat exposure and decision making with regard to therapeutics and, on a larger scale, Public Health. Microarray analysis of gene expression in cancer has already been put in clinical practice for the routine prognostic screening in patients with breast cancer. Our preliminary results demonstrate the diagnostic and prognostic value of microarray blood analysis in patients with Systemic Lupus Erythematosus, thus extending the application of this technology beyond cancer and towards immune dysfunction. Our strategy will be based on a comprehensive analysis of human cells response to different classes of pathogenic microorganisms in vitro and in vivo. This will allow identification of common molecular host biosignatures induced by different microbial infections, prompt diagnosis of exposure and identification of a class of pathogen. The goal of this Core is to provide Affymetrix based analysis of gene expression patterns of human cells exposed to Class A-C pathogens in vitro and in vivo. The objectives are: 1) To establish and distribute within the Center relevant standard operating procedures (SOP's). 2) To analyze, using Affymetrix technology and GeneSpring expression analysis software, samples obtained from Investigators of the Center. 3) To validate expression levels of candidate genes by real-time PCR. 4) To organize and maintain LIMS and Microsoft Access database system, which contains > 500 samples. 5) To be abreast with progresses in the field, most particularly technology and analysis software. The Core will provide support and expertise to virtually all Center's Investigators.